TAK-018 for Prevention of the Recurrence of Postoperative Crohn's Disease (CD)
Status:
Recruiting
Trial end date:
2022-10-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of TAK-018 in reducing endoscopic
recurrence of intestinal inflammation in postoperative participants with CD after a planned
laparoscopic ileocecal resection with primary anastomosis.